A method for predicting the responsiveness of lymphomas to PI3K pathway inhibitors

Value Proposition Lymphomas are highly diverse and among the most...

MORE >

MEK inhibitors as therapeutic agents and diagnostic tools for hemoglobinopathies, including thalassemia

Value Proposition Patients with sickle cell disease experience acute vaso-occlusive...

MORE >

G protein-coupled receptor kinase 2 and beta arrestins as therapeutic targets and diagnostic tools for hemoglobinopathies

Value Proposition Sickle cell disease affects millions of people throughout...

MORE >